Randal W. Scott is Director of Talis Biomedical Corp. Currently has a direct ownership of 20,000 shares of TLIS, which is worth approximately $34,600. The most recent transaction as insider was on May 17, 2021, when has been sold 11,000 shares (Common Stock) at a price of $10.11 per share, resulting in proceeds of $111,210. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K
0% 3M change
0% 12M change
Total Value Held $34,600

Randal W. Scott Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2021
BUY
Open market or private purchase
$111,210 $10.11 p/Share
11,000 Added 35.48%
20,000 Common Stock
May 14 2021
BUY
Open market or private purchase
$91,440 $10.16 p/Share
9,000 Added 50.0%
9,000 Common Stock

Also insider at

BBIO
BridgeBio Pharma, Inc. Healthcare
NVTA
Invitae Corp Healthcare
RWS

Randal W. Scott

Director
San Francisco, CA

Track Institutional and Insider Activities on TLIS

Follow Talis Biomedical Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TLIS shares.

Notify only if

Insider Trading

Get notified when an Talis Biomedical Corp insider buys or sells TLIS shares.

Notify only if

News

Receive news related to Talis Biomedical Corp

Track Activities on TLIS